{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34797348", "DateCompleted": {"Year": "2022", "Month": "02", "Day": "14"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "08"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["e27918", "10.1097/MD.0000000000027918"], "Journal": {"ISSN": "1536-5964", "JournalIssue": {"Volume": "100", "Issue": "46", "PubDate": {"Year": "2021", "Month": "Nov", "Day": "19"}}, "Title": "Medicine", "ISOAbbreviation": "Medicine (Baltimore)"}, "ArticleTitle": "Synergistic effects of herbal medicines and anticancer drugs: A protocol for systematic review and meta-analysis.", "Pagination": {"StartPage": "e27918", "MedlinePgn": "e27918"}, "Abstract": {"AbstractText": ["An increasing number of studies have been reporting combination therapy using herbal medicines and anticancer drugs, and the synergistic effects of this combination have gained much attention across the medical community. In this study, we will review and summarize all published studies that have investigated the synergistic interaction between herbal medicines and anticancer drugs.", "We will search the PubMed, Embase, and Cochrane Library databases. Studies investigated the synergistic interaction between herbal medicines and anticancer drugs will be included. The selection and extraction process will be performed by 2 independent reviewers, and we will perform qualitative synthesis.", "The present study is being performed to investigate the herbal medicines and anticancer drugs that are used concomitantly, and to determine the combinations that are expected to show a synergistic effect. This knowledge will provide new insights into the possible role of herbal medicines in anticancer treatment.", "Trial registration: OSF Registration number: DOI 10.17605/OSF.IO/H5QS9."], "CopyrightInformation": "Copyright \u00a9 2021 the Author(s). Published by Wolters Kluwer Health, Inc."}, "AuthorList": [{"Identifier": ["0000-0002-7078-0079"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Preventive Medicine, College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea."}], "LastName": "Cheon", "ForeName": "Chunhoo", "Initials": "C"}], "GrantList": [{"GrantID": "2020R1A5A2019413", "Agency": "National Research Foundation of Korea", "Country": ""}, {"GrantID": "HI18C2382", "Agency": "Korea Health Industry Development Institute", "Country": "Republic of Korea"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Medicine (Baltimore)", "NlmUniqueID": "2985248R", "ISSNLinking": "0025-7974"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}], "MeshHeadingList": [{"QualifierName": ["therapeutic use"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": [], "DescriptorName": "Complementary Therapies"}, {"QualifierName": [], "DescriptorName": "Drug Synergism"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Meta-Analysis as Topic"}, {"QualifierName": ["therapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Systematic Reviews as Topic"}], "CoiStatement": "The authors have no conflicts of interests to disclose."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": " World Health Organization. Cancer, fact sheet. 2021; Available at:  https://www.who.int/news-room/fact-sheets/detail/cancer. Accessed 19 October, 2021."}, {"Citation": "Peng F, Xie X, Peng C. Chinese herbal medicine-based cancer therapy: novel anticancer agents targeting MicroRNAs to regulate tumor growth and metastasis. Am J Chin Med 2019;47:1711\u201335.", "ArticleIdList": ["31801358"]}, {"Citation": "Kim TW, Cheon C, Ko SG. SH003 activates autophagic cell death by activating ATF4 and inhibiting G9a under hypoxia in gastric cancer cells. Cell Death Dis 2020;11:717.", "ArticleIdList": ["PMC7468158", "32879309"]}, {"Citation": "Choi YJ, Choi YK, Lee KM, Cho SG, Kang SY, Ko SG. SH003 induces apoptosis of DU145 prostate cancer cells by inhibiting ERK-involved pathway. BMC Complement Altern Med 2016;16:507.", "ArticleIdList": ["PMC5142381", "27927199"]}, {"Citation": "Choi HS, Kim MK, Lee K, et al. . SH003 represses tumor angiogenesis by blocking VEGF binding to VEGFR2. Oncotarget 2016;7:32969\u201379.", "ArticleIdList": ["PMC5078067", "27105528"]}, {"Citation": "Park CR, Lee JS, Son CG, Lee NH. A survey of herbal medicines as tumor microenvironment-modulating agents. Phytother Res 2021;35:78\u201394.", "ArticleIdList": ["32658314"]}, {"Citation": "Bayat Mokhtari R, Homayouni TS, Baluch N, et al. . Combination therapy in combating cancer. Oncotarget 2017;8:38022\u201343.", "ArticleIdList": ["PMC5514969", "28410237"]}, {"Citation": "Lee YK, Bae K, Yoo HS, Cho SH. Benefit of adjuvant traditional herbal medicine with chemotherapy for resectable gastric cancer. Integr Cancer Ther 2018;17:619\u201327.", "ArticleIdList": ["PMC6142080", "29614889"]}, {"Citation": "Cheon C, Ko SG. A phase I study to evaluate the safety of the herbal medicine SH003 in patients with solid cancer. Integr Cancer Ther 2020;19:1534735420911442.", "ArticleIdList": ["PMC7081467", "32186413"]}, {"Citation": "Chung VCH, Wu X, Lu P, et al. . Chinese herbal medicine for symptom management in cancer palliative care: systematic review and meta-analysis. Medicine (Baltimore) 2016;95:e2793.", "ArticleIdList": ["PMC4998628", "26886628"]}, {"Citation": "Moher D, Shamseer L, Clarke M, et al. . Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015;4:01.", "ArticleIdList": ["PMC4320440", "25554246"]}, {"Citation": "Sterne JAC, Savovi\u0107 J, Page MJ, et al. . RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019;366:l4898.", "ArticleIdList": ["31462531"]}, {"Citation": "Carugo A, Draetta GF. Academic discovery of anticancer drugs: historic and future perspectives. Ann Rev Cancer Biol 2019;3:385\u2013408."}, {"Citation": "Tan JB, Wang T, Kirshbaum MN, et al. . Acupoint stimulation for cancer-related fatigue: a quantitative synthesis of randomised controlled trials. Complement Ther Clin Pract 2021;45:101490.", "ArticleIdList": ["34638053"]}, {"Citation": "Liu W, Lopez G, Narayanan S, et al. . Acupuncture for cancer-related anorexia: a review of the current evidence. Curr Oncol Rep 2021;23:82.", "ArticleIdList": ["33948746"]}, {"Citation": "Guerra-Mart\u00edn MD, Tejedor-Bueno MS, Correa-Casado M. Effectiveness of complementary therapies in cancer patients: a systematic review. Int J Environ Res Public Health 2021;18:03.", "ArticleIdList": ["PMC7908482", "33498883"]}, {"Citation": "Deng G, Huang X, Tu M, et al. . Efficacy and safety of moxibustion in the treatment of cancer-related fatigue: a protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e24857.", "ArticleIdList": ["PMC7939204", "33655946"]}, {"Citation": "Cheon C, Ko SG. Phase I study to evaluate the maximum tolerated dose of the combination of SH003 and docetaxel in patients with solid cancer: a study protocol. Medicine (Baltimore) 2020;99:e22228.", "ArticleIdList": ["PMC7505292", "32957363"]}, {"Citation": "Changou CA, Shiah HS, Chen LT, et al. . A Phase II clinical trial on the combination therapy of PHY906 plus capecitabine in hepatocellular carcinoma. Oncologist 2021;26:e367\u201373.", "ArticleIdList": ["PMC7930412", "33140457"]}, {"Citation": "Jeong MS, Lee KW, Choi YJ, et al. . Synergistic antitumor activity of SH003 and docetaxel via EGFR signaling inhibition in non-small cell lung cancer. Int J Mol Sci 2021;22:16.", "ArticleIdList": ["PMC8395077", "34445110"]}, {"Citation": "Yang X, Lam W, Jiang Z, et al. . YIV-906 potentiated anti-PD1 action against hepatocellular carcinoma by enhancing adaptive and innate immunity in the tumor microenvironment. Sci Rep 2021;11:13482.", "ArticleIdList": ["PMC8242098", "34188068"]}, {"Citation": "Liu S, He X, Man VH, Ji B, Liu J, Wang J. New application of in silico methods in identifying mechanisms of action and key components of anti-cancer herbal formulation YIV-906 (PHY906). Phys Chem Chem Phys 2019;21:23501\u201313.", "ArticleIdList": ["31617551"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "11", "Day": "5"}, {"Year": "2021", "Month": "11", "Day": "8"}, {"Year": "2021", "Month": "11", "Day": "19", "Hour": "12", "Minute": "15"}, {"Year": "2021", "Month": "11", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "11", "Day": "19"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34797348", "PMC8601363", "10.1097/MD.0000000000027918", "00005792-202111190-00078"]}}], "PubmedBookArticle": []}